HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ABUS
Arbutus Biopharma Corp
Healthcare Biotechnology · British Columbia, Canada · Reports in usd
Market Cap: $798.1M
Market Cap
$798.1M
Enterprise Val
$710.9M
P/E Ratio
-23.82
P/B Ratio
10.42
Trailing PEG (1Y)
0.28
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$76.6M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-42.39%
Return on Assets-32.48%
Current Ratio15.73
Debt/Equity0.05
LT Debt/Equity0.05
Revenue Per Share0.01

Income Statement

Dec 31, 2025
Revenue$1.1M
Cost of Revenue$0.00
Gross Profit$1.1M
R&D$5.0M
SG&A$3.7M
Operating Expenses$9.0M
Operating Income-$7.9M
Interest Expense$18.0K
Tax Expense$0.00
Net Income-$3.8M
EPS (Basic)$-0.01
EPS (Diluted)$-0.01
EBIT-$3.7M
EBITDA-$3.7M
Consolidated Income-$3.8M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$18.0M
Accounts Receivable$1.4M
Inventory$0.00
Current Assets$94.5M
LT Investments$0.00
Property, Plant & Equipment$32.0K
Intangibles$0.00
Non-Current Assets$162.0K
Total Assets$94.6M
Accounts Payable$5.5M
Current Debt$547.0K
Current Liabilities$6.0M
LT Debt$3.6M
Non-Current Liabilities$12.0M
Total Liabilities$18.0M
Total Debt$4.2M
Retained Earnings-$1.38B
Shareholder Equity$76.6M
Shares Outstanding192,324,017

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$4.7M
Investing Cash Flow-$1.4M
Financing Cash Flow$1.6M
CapEx$355.0K
Free Cash Flow-$4.3M
Depreciation & Amort.$11.0K
Stock-Based Comp$1.3M
Acquisitions / Disposals$0.00
Investment Activity-$1.7M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$1.6M
Dividends Paid$0.00
Net Change in Cash-$4.4M
Data cached · Meta live · Daily live · Statements live · TTL 24h